These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 10651534

  • 1. [New drugs in gastrointestinal oncology. Current status and future directions].
    Conroy T, Paillot B, Adenis A.
    Gastroenterol Clin Biol; 1999 Nov; 23(11):1145-65. PubMed ID: 10651534
    [No Abstract] [Full Text] [Related]

  • 2. New drug for therapy of non-small cell lung cancer.
    Klastersky J.
    Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
    [No Abstract] [Full Text] [Related]

  • 3. Colon cancer: new drug options improve on 5-FU.
    McCann J.
    J Natl Cancer Inst; 1998 Jul 01; 90(13):963-5. PubMed ID: 9665142
    [No Abstract] [Full Text] [Related]

  • 4. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP.
    Rev Mal Respir; 1997 Apr 01; 14(2):154-6. PubMed ID: 9198842
    [No Abstract] [Full Text] [Related]

  • 5. [New promising anticancer drugs for lung cancer].
    Ariyoshi Y, Sugiura T.
    Gan To Kagaku Ryoho; 1994 Nov 01; 21(15):2578-84. PubMed ID: 7979416
    [Abstract] [Full Text] [Related]

  • 6. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
    Meert AP, Berghmans T, Branle F, Lemaître F, Mascaux C, Rubesova E, Vermylen P, Paesmans M, Sculier JP.
    Anticancer Res; 1999 Nov 01; 19(5C):4379-90. PubMed ID: 10650780
    [Abstract] [Full Text] [Related]

  • 7. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR.
    Oncology (Williston Park); 2001 Jul 01; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [Abstract] [Full Text] [Related]

  • 8. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec 01; 14(80):230-3. PubMed ID: 16400749
    [Abstract] [Full Text] [Related]

  • 9. Recent development of anti-cancer drugs for treatment of GI malignancies in Japan.
    Taguchi T.
    Gan To Kagaku Ryoho; 2002 Feb 01; 29 Suppl 1():76-80. PubMed ID: 11890118
    [No Abstract] [Full Text] [Related]

  • 10. New systemic drugs in the treatment of gastrointestinal cancer.
    Ogawa M.
    Curr Opin Oncol; 1996 Jul 01; 8(4):317-20. PubMed ID: 8869807
    [Abstract] [Full Text] [Related]

  • 11. Radiosensitization with chemotherapeutic agents.
    Caffo O.
    Lung Cancer; 2001 Dec 01; 34 Suppl 4():S81-90. PubMed ID: 11742709
    [Abstract] [Full Text] [Related]

  • 12. Treatment of advanced disease and new drugs.
    Frustaci S, Buonadonna A, La Mura N, Berretta M, De Paoli A.
    Suppl Tumori; 2003 Dec 01; 2(5):S48-50. PubMed ID: 12914391
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ, Gandara DR.
    Cancer Chemother Pharmacol; 1996 Dec 01; 37(5):385-93. PubMed ID: 8599859
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of cancer chemotherapy in relation to the pretreatment number of lymphocytes in patients with metastatic solid tumors.
    Lissoni P, Brivio F, Fumagalli L, Messina G, Ghezzi V, Frontini L, Giani L, Vaghi M, Ardizzoia A, Gardani GS.
    Int J Biol Markers; 2004 Dec 01; 19(2):135-40. PubMed ID: 15255546
    [Abstract] [Full Text] [Related]

  • 16. New drugs in the treatment of colorectal carcinoma.
    Punt CJ.
    Cancer; 1998 Aug 15; 83(4):679-89. PubMed ID: 9708931
    [Abstract] [Full Text] [Related]

  • 17. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
    Health Technol Assess; 2001 Aug 15; 5(32):1-195. PubMed ID: 12065068
    [Abstract] [Full Text] [Related]

  • 18. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
    Bunn PA, Kelly K.
    Clin Cancer Res; 1998 May 15; 4(5):1087-100. PubMed ID: 9607565
    [Abstract] [Full Text] [Related]

  • 19. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
    Ferrigno D, Buccheri G.
    Lung Cancer; 2000 Aug 15; 29(2):91-104. PubMed ID: 10963840
    [Abstract] [Full Text] [Related]

  • 20. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA, Rigas JR, Grant SC, Pisters KM, Kris MG.
    Chest; 1995 Jun 15; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.